
Karen Cheng
Examiner (ID: 18485, Phone: (571)270-7381 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1623, 1621, 1622, 1626 |
| Total Applications | 1007 |
| Issued Applications | 710 |
| Pending Applications | 93 |
| Abandoned Applications | 234 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14761977
[patent_doc_number] => 10392373
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Oxazole derivatives that inhibit Syk
[patent_app_type] => utility
[patent_app_number] => 15/760362
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15588
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760362
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760362 | Oxazole derivatives that inhibit Syk | Sep 15, 2016 | Issued |
Array
(
[id] => 13410005
[patent_doc_number] => 20180256545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => Mono- or Di-Substituted Indole Derivatives As Dengue Viral Replication Inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/759846
[patent_app_country] => US
[patent_app_date] => 2016-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15759846
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/759846 | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | Sep 14, 2016 | Issued |
Array
(
[id] => 11421285
[patent_doc_number] => 20170029429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'NOVEL CHIRAL N-ACYL-5,6,7,(8-SUBSTITUTED)-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-a]PYRAZINES AS SELECTIVE NK-3 RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR USE IN NK-3 RECEPTOR MEDIATED DISORDERS AND CHIRAL SYNTHESIS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/259922
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35220
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15259922
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/259922 | Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof | Sep 7, 2016 | Issued |
Array
(
[id] => 13278393
[patent_doc_number] => 10150768
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-11
[patent_title] => Guanidine substituted imidazo[4,5-c] ring compounds
[patent_app_type] => utility
[patent_app_number] => 15/753560
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17692
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753560
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/753560 | Guanidine substituted imidazo[4,5-c] ring compounds | Aug 25, 2016 | Issued |
Array
(
[id] => 11499130
[patent_doc_number] => 20170073316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto'
[patent_app_type] => utility
[patent_app_number] => 15/247131
[patent_app_country] => US
[patent_app_date] => 2016-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20647
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15247131
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/247131 | Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto | Aug 24, 2016 | Issued |
Array
(
[id] => 11324865
[patent_doc_number] => 20160355477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/242160
[patent_app_country] => US
[patent_app_date] => 2016-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23519
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15242160
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/242160 | INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF | Aug 18, 2016 | Abandoned |
Array
(
[id] => 13386315
[patent_doc_number] => 20180244699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => 1-HYDROXY-3H-2,1-BENZOXABOROLE DERIVATIVES AND THEIR USE AS MICROBIOCIDES
[patent_app_type] => utility
[patent_app_number] => 15/753460
[patent_app_country] => US
[patent_app_date] => 2016-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 403
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753460
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/753460 | 1-HYDROXY-3H-2,1-BENZOXABOROLE DERIVATIVES AND THEIR USE AS MICROBIOCIDES | Aug 15, 2016 | Abandoned |
Array
(
[id] => 13354343
[patent_doc_number] => 20180228711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => 3-(4-HYDROXYPHENYL) PROPANOIC ACID AMIDE FOR USE IN TISSUE REPAIR AND/OR SKIN BRIGHTENING
[patent_app_type] => utility
[patent_app_number] => 15/752001
[patent_app_country] => US
[patent_app_date] => 2016-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15752001
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/752001 | 3-(4-HYDROXYPHENYL) PROPANOIC ACID AMIDE FOR USE IN TISSUE REPAIR AND/OR SKIN BRIGHTENING | Aug 11, 2016 | Abandoned |
Array
(
[id] => 11289069
[patent_doc_number] => 20160339000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/228681
[patent_app_country] => US
[patent_app_date] => 2016-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87132
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15228681
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/228681 | Triazolone compounds as mPGES-1 inhibitors | Aug 3, 2016 | Issued |
Array
(
[id] => 13342645
[patent_doc_number] => 20180222862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => NOVEL 3-INDOL SUBSTITUTED DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
[patent_app_type] => utility
[patent_app_number] => 15/749963
[patent_app_country] => US
[patent_app_date] => 2016-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15749963
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/749963 | 3-indol substituted derivatives, pharmaceutical compositions and methods for use | Aug 3, 2016 | Issued |
Array
(
[id] => 13354481
[patent_doc_number] => 20180228780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => 3-(1H-PYRROLO[2,3-C]PYRIDIN-2-YL)-1H-INDAZOLES AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/749592
[patent_app_country] => US
[patent_app_date] => 2016-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15749592
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/749592 | 3-(1H-PYRROLO[2,3-C]PYRIDIN-2-YL)-1H-INDAZOLES AND THERAPEUTIC USES THEREOF | Aug 2, 2016 | Abandoned |
Array
(
[id] => 13298335
[patent_doc_number] => 20180200704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => IMPROVED OLEFIN METATHESIS CATALYSTS
[patent_app_type] => utility
[patent_app_number] => 15/742668
[patent_app_country] => US
[patent_app_date] => 2016-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13949
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15742668
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/742668 | Olefin metathesis catalysts | Jul 7, 2016 | Issued |
Array
(
[id] => 13314015
[patent_doc_number] => 20180208544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => AN IMPROVED PROCESS FOR THE PREPARATION OF BACLOFEN AND ITS INTERMEDIATE
[patent_app_type] => utility
[patent_app_number] => 15/744272
[patent_app_country] => US
[patent_app_date] => 2016-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3792
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744272
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/744272 | AN IMPROVED PROCESS FOR THE PREPARATION OF BACLOFEN AND ITS INTERMEDIATE | Jul 7, 2016 | Abandoned |
Array
(
[id] => 12960178
[patent_doc_number] => 09872862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Salt form of a human histone methyltransferase EZH2 inhibitor
[patent_app_type] => utility
[patent_app_number] => 15/199522
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 21
[patent_no_of_words] => 23223
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15199522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/199522 | Salt form of a human histone methyltransferase EZH2 inhibitor | Jun 29, 2016 | Issued |
Array
(
[id] => 12099188
[patent_doc_number] => 09856276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-02
[patent_title] => 'Compounds useful in the synthesis of halichondrin B analogs'
[patent_app_type] => utility
[patent_app_number] => 15/196600
[patent_app_country] => US
[patent_app_date] => 2016-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13762
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15196600
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/196600 | Compounds useful in the synthesis of halichondrin B analogs | Jun 28, 2016 | Issued |
Array
(
[id] => 16696620
[patent_doc_number] => 10947200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Substituted imidazolium sulfuranes and their use
[patent_app_type] => utility
[patent_app_number] => 15/739239
[patent_app_country] => US
[patent_app_date] => 2016-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 8135
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15739239
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/739239 | Substituted imidazolium sulfuranes and their use | Jun 20, 2016 | Issued |
Array
(
[id] => 11100797
[patent_doc_number] => 20160297767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'ESTROGEN RECEPTOR MODULATORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/186246
[patent_app_country] => US
[patent_app_date] => 2016-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88723
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15186246
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/186246 | Estrogen receptor modulators and uses thereof | Jun 16, 2016 | Issued |
Array
(
[id] => 13492927
[patent_doc_number] => 20180298006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Fused Tricyclic Imidazo Pyrazines as Modulators of TNF Activity
[patent_app_type] => utility
[patent_app_number] => 15/580137
[patent_app_country] => US
[patent_app_date] => 2016-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580137
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/580137 | Fused tricyclic imidazo pyrazines as modulators of TNF activity | Jun 6, 2016 | Issued |
Array
(
[id] => 15393843
[patent_doc_number] => 10537558
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto
[patent_app_type] => utility
[patent_app_number] => 15/578585
[patent_app_country] => US
[patent_app_date] => 2016-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96198
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 914
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578585
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/578585 | Substituted pyrazole and pyrrole compounds and methods for using them for inhibition of initiation of translation and treatment of diseases and disorders relating thereto | May 31, 2016 | Issued |
Array
(
[id] => 13209085
[patent_doc_number] => 10118899
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Production method of enzalutamide crystal form
[patent_app_type] => utility
[patent_app_number] => 15/577007
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 6056
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577007
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/577007 | Production method of enzalutamide crystal form | May 26, 2016 | Issued |